Latest filing published 21 May 2025 for INOVIO PHARMACEUTICALS, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Lota S. Zoth span 2 companies, the busiest being Inovio Pharmaceuticals, Inc. and Lumos Pharma, Inc. Between 14 May 2021 and 21 May 2025, the trades on record add up to 9 filings.
The open-market record consists of 1 sale worth €2,980, with no purchase. The rest of the record consists of 1 share grant and 6 option exercises.
The newest entry dates from 21 May 2025: an option exercise, in Inovio Pharmaceuticals, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations